• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amprius Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Business Highlights

    3/4/26 4:05:00 PM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous
    Get the next $AMPX alert in real time by email
    • Q4 revenue up 137% to $25.2 million; full-year 2025 revenue up over 3X to $73.0 million
    • Net loss of $44.0 million reflects one time impairment charges of $22.5 million as Q4 gross margin improved to 24% driving first positive quarterly non-GAAP adjusted EBITDA of $1.8 million
    • Expecting 2026 revenue growth of at least 70% to $125 million or more, with net loss below $8 million, and positive non-GAAP Adjusted EBITDA of at least $4 million

    Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE:AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced financial results for the fourth quarter and full year ended December 31, 2025, and discussed recent business developments.

    Revenue for the fourth quarter of 2025 was $25.2 million, compared to $10.6 million in the fourth quarter of 2024. Net loss was $24.4 million, compared to a net loss of $11.4 million in the fourth quarter of 2024. Net loss per share was $0.18, compared to a net loss per share of $0.10 in the fourth quarter of 2024. Results reflect a fourth quarter 2025 charge of $22.5 million reflecting the impairment of assets linked to a facility in Colorado, discussed below, along with other one-time fixed asset write-downs. Adjusting for these one-time charges, the Company's net loss for the fourth quarter would have been $1.9 million, or $0.01 per share.

    Revenue for the full year 2025 was $73.0 million, compared to $24.2 million in 2024, an increase of 202%. Net loss for the year was $44.0 million, compared to a net loss of $44.7 million in 2024. Net loss per share for the year was $0.35, compared to a loss of $0.45 per share in 2024. Adjusting for the one-time charges in Q4 of $22.5 million, the Company's full-year 2025 net loss would have been $21.5 million, or $0.17 cents per share.

    Q4 2025 Financial Highlights

    • Record revenue of $25.2 million, up 18% sequentially and 137% year-over-year (YoY)
    • Delivered gross margin of 24%, with gross profit improving 80% sequentially and 365% YoY
    • Net loss of $24.4 million, a $20.5 million increase sequentially and $13.0 million increase YoY. Excluding the $22.5 million charge, described above, adjusted net loss was $1.9 million.
    • Non-GAAP Adjusted EBITDA of $1.8 million, up $1.6 million sequentially and $6.5 million YoY

    Full Year 2025 Financial Highlights

    • Total revenue of $73.0 million, up 202% from 2024
    • Gross margins of 11%, an 87-percentage point improvement over 2024
    • Net loss of $44.0 million, a $0.6 million improvement YoY. Excluding a $22.5 million loss on impairment of long-lived assets and retirement of property, plant and equipment, adjusted net loss was $21.5 million
    • Non-GAAP Adjusted EBITDA of $(5.3) million, an $18.1 million YoY improvement
    • Ended the year with cash and cash equivalents of $91.9 million

    "For Amprius, 2025 marked a year of meaningful commercial progress, as we expanded our customer base to over 550, increased revenue by over 3x, and advanced the adoption of our silicon anode batteries across multiple end markets," said Amprius CEO Tom Stepien. "Growing demand from existing customers, new program wins, and improved execution across our manufacturing partners drove strong momentum throughout the year. Looking ahead to 2026, we plan to leverage our enhanced supply chain to scale production and meet accelerating market demand, supporting continued accretive growth."

    Reconciliations of GAAP net loss to non-GAAP Adjusted EBITDA and adjusted non-GAAP net loss excluding one-time charges are provided in the financial schedules that are part of this press release. An explanation of these non-GAAP financial measures is also included below under the heading "Non-GAAP Financial Measures."

    Quarterly Financial Comparison

    $ in millions

    Metric

    Q4 2025

    Q4 2024

    Delta

    Improvement

    Revenue

    25.2

    10.6

    14.6

    137%

    Gross Profit (Loss)

    6.0

    (2.3)

    8.2

    365%

    % Margin

    24%

    (21%)

     

     

    GAAP Net (Loss)

    (24.4)

    (11.4)

    (13.0)

    (114%)

    % Margin

    (97%)

    (107%)

     

     

    Adj. Net (Loss)

    (1.9)

    (9.6)

    7.7

    80%

    % Margin

    (7%)

    (90%)

     

     

    Adjusted EBITDA

    1.8

    (4.8)

    6.5

    137%

    % Margin

    7%

    (45%)

     

     

     

    Full Year Financial Comparison

    $ in millions

    Metric

    2025

    2024

    Delta

    Improvement

    Revenue

    73.0

    24.2

    48.8

    202%

    Gross Profit (Loss)

    8.3

    (18.3)

    26.6

    145%

    % Margin

    11%

    (76%)

     

     

    GAAP Net (Loss)

    (44.0)

    (44.7)

    0.6

    1%

    % Margin

    (60%)

    (185%)

     

     

    Adj. Net (Loss)

    (21.5)

    (42.8)

    21.3

    50%

    % Margin

    (29%)

    (177%)

     

     

    Adjusted EBITDA

    (5.3)

    (23.5)

    18.1

    77%

    % Margin

    (7%)

    (97%)

     

     

    Business Highlights

    • Added $2.8 million to Amprius' existing agreement with the Defense Innovation Unit (DIU), an arm of the U.S. Department of War, bringing the total DIU-Amprius agreement for NDAA-compliant advanced drone batteries to $14.8 million. The DIU views secure supply chains for battery technology suitable for defense applications as strategically important.
    • Secured the first U.S.-based manufacturing partner to scale domestic SiCore battery production, positioning Amprius to support the rising demand for cells compliant with the recently updated National Defense Authorization Act (NDAA).
    • Sourced NDAA-compliant suppliers for the internal cell that are required for full NDAA compliance and finalized the selection of all 11 components for current cell designs.
    • Added three additional contract manufacturers to the Amprius Korea Battery Alliance, broadening Amprius' global manufacturing network and providing direct access to Korea's advanced battery production ecosystem.
    • Selected by Nokia Drone Networks to power its next-generation drone systems following extensive qualification and testing that demonstrated the endurance, power delivery, and safety performance needed for Nokia's application.
    • In January 2026, terminated the Company's 15-year lease for a facility in Brighton, Colorado for $20.0 million as the Company moves forward with a capital-light manufacturing model; thereby eliminating an over $110 million lease and related expense obligation.
    • Appointed Tom Stepien as Chief Executive Officer to lead the Company's next growth phase following Dr. Kang Sun's retirement.

    2026 Financial Outlook

    Amprius issues its 2026 full year outlook as follows:

    • Total revenue is expected to be at least $125.0 million
    • Net loss is expected to be less than $8.0 million
    • Net loss per share is expected to be under $0.06
    • Adjusted EBITDA is expected to be at least $4.0 million
    • Capital expenditure is expected to be under $10.0 million

    The Company's 2026 outlook assumes depreciation and amortization of $4.7 million, stock-based compensation expense of $8.3 million, interest income of $1.0 million, and weighted average shares outstanding of 132.0 million for the full year.

    Amprius CFO Ricardo C. Rodriguez added: "Last year presented early evidence of the potential of our business model, with the revenue base steadily increasing and margins improving. In 2026, our team is energized to continue delivering what we believe is a meaningful step function in growth and profitability with a clean balance sheet and a scale-enabling cost structure."

    Amprius may recognize additional charges, realize gains or losses, incur financing costs or interest expense, or experience other events in 2026, including those related to the planned capacity expansion, supply chain disruptions, or further cost inflation, that could cause actual results to vary materially from this outlook. See Special Note Regarding Forward-Looking and Cautionary Statements below.

    Conference Call and Webcast Notification

    A conference call with Amprius management to discuss fourth quarter and 2025 results and recent business developments will be held on Thursday, March 5, 2026, at 8:30 a.m. EST. During the call, management will respond to questions concerning, but not limited to, Amprius' financial performance, business conditions, and financial outlook. Management's discussion and responses could contain information that has not been previously disclosed.

    Shareholders and other interested parties may call 866-424-3442 (domestic) or +1 201-689-8548 (international) and reference conference ID "13758666" to participate in the conference call. In addition, the conference call and an accompanying slide presentation will be available live as a listen-only webcast here and hosted at the Investors section of Amprius' website, ir.amprius.com.

    Amprius uses the Investor section on the website to disclose material information for the purposes of the Securities and Exchange Commission's (SEC) Regulation Fair Disclosure. Shareholders and other interested are encouraged to monitor this website in addition to Amprius' other public announcements and SEC filings as information posted on that page could be deemed to be material information.

    Following the live event, an archived version of the webcast will be available on Amprius' website for convenient on-demand replay. A copy of this press release is posted in the Investors section on Amprius' website.

    About Amprius Technologies, Inc.

    Amprius Technologies, Inc. is a leader in advanced lithium-ion battery technology, delivering high-energy and high-power silicon anode batteries with up to twice the energy density, range, and flight time of conventional graphite-based cells. Headquartered in Fremont, California, Amprius operates an R&D lab and pilot manufacturing facility for silicon anodes and cells. To support scalable production, the Company employs a contract manufacturing strategy, enabling rapid capacity expansion with minimal capital investment. Committed to driving innovation in energy storage, Amprius powers next-generation applications in aerospace, defense, and mobility. For additional information, please visit amprius.com and the Company's LinkedIn.

    Forward-Looking Statements

    This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995, each as amended, including Amprius' expectations, hopes, beliefs, intentions or strategies regarding the future. Forward-looking statements may be identified by the use of words such as "estimate," "plan," "project," "forecast," "intend," "expect," "anticipate," "believe," "seek," "will" or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the ability of Amprius to serve more customers, bring in additional revenue and expand applications, the strategic benefits of Amprius' Fremont, California pilot line to its business, the ability of Amprius to further expand this pilot line and the benefits of such expansion to Amprius, the benefits of the existing governmental award and recent governmental policies to Amprius' business, the capacity of Amprius' contract manufacturing partners with respect to Amprius' batteries, Amprius' ability to meet customers demand with contract manufacturing capacities, the development and size of the addressable markets for Amprius' batteries and the benefits of the expansion of such addressable markets, the potential application and performance of Amprius' batteries, the ability of Amprius to secure additional contract manufacturers that can offer greater geographic diversification and operating flexibility, Amprius' liquidity position, capital strategy, strategic business plans, and Amprius' financial and business performance. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of Amprius' management and are not predictions of actual performance. These forward-looking statements are not intended to serve as, and must not be relied upon by any investors as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond Amprius' control. These forward-looking statements are subject to a number of risks and uncertainties, including market demands for SiCore batteries; the ability of Amprius to deliver high performance products to customers at acceptable prices and meet their demands via the contract manufacturing arrangements; third-party producers of Amprius batteries continuing to produce such batteries in the expected quantities and caliber and at the expected prices; Amprius' customers continuing to purchase batteries from Amprius; risks related to the rollout of Amprius' business and the timing of expected business milestones; the effects of competition on Amprius' business; Amprius' liquidity position and its ability to raise additional capital; the possibility that Amprius may be adversely affected by economic, business or competitive factors, including supply chain interruptions, further cost inflation and developments in alternative technologies, and may not be able to manage other risks and uncertainties; the effect of macroeconomic factors, such as increased tariffs and related retaliatory actions, trade barriers, economic downturns and other business interruptions affecting the global economy and capital markets, on Amprius' business; changes in governmental policies impacting Amprius' customers and addressable markets; and changes in other domestic and foreign business, market, financial, political and legal conditions. More information on these risks and uncertainties that may impact the operations and projections discussed herein can be found in the documents Amprius filed from time to time with the SEC, all of which are available on the SEC's website at www.sec.gov. If any of these risks materialize or Amprius' assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Amprius does not presently know or that Amprius currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Amprius' expectations, plans or forecasts of future events and views as of the date of this press release. These forward-looking statements should not be relied upon as representing Amprius' assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements. Except as required by law, Amprius specifically disclaims any obligation to update any forward-looking statements.

    Non-GAAP Financial Measures

    To supplement our financial results presented on a basis in conformity with generally accepted accounting principles in the United States ("GAAP"), we use non-GAAP measures: Adjusted EBITDA, which excludes from our GAAP net loss, interest, taxes, depreciation and amortization, as well as other significant expenses including stock-based compensation; and Adjusted net loss, which excludes from our GAAP net loss, significant one-time items that we believe are helpful in understanding our past financial performance. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

    Management believes that these non-GAAP financial measures reflect our ongoing business in a manner that allows for meaningful comparisons and analysis of trends in its business, as it excludes expenses and gains not reflective of ongoing operating results or that may be infrequent and/or unusual in nature. We exclude the operating costs for our facility in Colorado, as these costs were recurring in the past but with our decision to terminate the lease, they are no longer indicative of our ongoing operational results. We also adjust for the effect of stock-based compensation expenses noting that such expenses will recur in future periods. Although stock-based compensation is a key incentive offered to our employees, we continue to evaluate our business performance internally excluding stock-based compensation expenses.

    Management also believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating our operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. These non-GAAP measures may not be comparable to similarly titled measures presented by other companies. In this press release, we provided a reconciliation of non-GAAP Adjusted EBITDA and Adjusted net loss to GAAP net loss, the most directly comparable GAAP financial measure.

    AMPRIUS TECHNOLOGIES, INC.
    CONDENSED CONSOLIDATED BALANCE SHEETS
    (Unaudited, in thousands, except share and par value data)
     

    December 31,

     

    2025

     

     

     

    2024

     

    ASSETS
    Current assets:
    Cash and cash equivalents

    $

    90,465

     

    $

    55,155

     

    Accounts receivable, net

     

    23,737

     

     

    5,580

     

    Inventories

     

    6,735

     

     

    6,574

     

    Deferred costs

     

    —

     

     

    —

     

    Prepaid expenses and other current assets

     

    5,500

     

     

    1,454

     

    Total current assets

     

    126,437

     

     

    68,763

     

    Non-current assets:
    Property, plant and equipment, net

     

    9,680

     

     

    17,481

     

    Operating lease right-of-use assets, net

     

    19,518

     

     

    33,512

     

    Other assets

     

    1,256

     

     

    1,369

     

    Total assets

    $

    156,891

     

    $

    121,125

     

    LIABILITIES AND STOCKHOLDERS' EQUITY
    Current liabilities:
    Accounts payable

    $

    6,700

     

    $

    7,424

     

    Accrued and other current liabilities

     

    3,666

     

     

    4,832

     

    Deferred grant

     

    2,738

     

     

    —

     

    Deferred revenue

     

    100

     

     

    1,638

     

    Operating lease liabilities

     

    4,665

     

     

    3,316

     

    Total current liabilities

     

    17,869

     

     

    17,210

     

    Non-current liabilities:
    Operating lease liabilities

     

    35,207

     

     

    34,443

     

    Total liabilities

     

    53,076

     

     

    51,653

     

    Commitments and contingencies
    Stockholders' equity:
    Preferred stock; $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding

     

    —

     

     

    —

     

    Common stock; $0.0001 par value; 950,000,000 shares authorized; 134,536,592 and 116,934,314 shares issued and outstanding at December 31, 2025 and 2024, respectively

     

    13

     

     

    12

     

    Additional paid-in capital

     

    322,156

     

     

    243,794

     

    Accumulated other comprehensive income

     

    4

     

     

    —

     

    Accumulated deficit

     

    (218,358

    )

     

    (174,334

    )

    Total stockholders' equity

     

    103,815

     

     

    69,472

     

    Total liabilities and stockholders' equity

    $

    156,891

     

    $

    121,125

     

     
    AMPRIUS TECHNOLOGIES, INC.
    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
    (Unaudited, in thousands, except share and per share data)
     

    Three months ended

    December 31,

     

    Year ended

    December 31,

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Revenue

    $

    25,234

     

    $

    10,631

     

    $

    73,011

     

    $

    24,167

     

    Cost of revenue

     

    19,267

     

     

    12,884

     

     

    64,747

     

     

    42,497

     

    Gross profit (loss)

     

    5,967

     

     

    (2,253

    )

     

    8,264

     

     

    (18,330

    )

    Gross margin

     

    24

    %

     

    (21

    )%

     

    11

    %

     

    (76

    )%

    Operating expenses:
    Research and development

     

    2,756

     

     

    2,284

     

     

    9,430

     

     

    7,344

     

    Selling, general and administrative

     

    6,157

     

     

    5,359

     

     

    22,956

     

     

    18,726

     

    Impairment and other

     

    22,524

     

     

    1,862

     

     

    22,524

     

     

    1,862

     

    Total operating expenses

     

    31,437

     

     

    9,505

     

     

    54,910

     

     

    27,932

     

    Loss from operations

     

    (25,470

    )

     

    (11,758

    )

     

    (46,646

    )

     

    (46,262

    )

    Other income, net:
    Interest income and other, net

     

    1,079

     

     

    340

     

     

    2,622

     

     

    1,591

     

    Total other income, net

     

    1,079

     

     

    340

     

     

    2,622

     

     

    1,591

     

    Net loss

    $

    (24,391

    )

    $

    (11,418

    )

    $

    (44,024

    )

    $

    (44,671

    )

    Weighted-average common shares outstanding:
    Basic and diluted

     

    132,064,482

     

     

    109,822,960

     

     

    124,639,991

     

     

    101,872,347

     

    Net loss per share of common stock:
    Basic and diluted

    $

    (0.18

    )

    $

    (0.10

    )

    $

    (0.35

    )

    $

    (0.45

    )

     
     
    AMPRIUS TECHNOLOGIES, INC.
    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
    (Unaudited, in thousands)
     

    Three months ended

    December 31,

     

    Year ended

    December 31,

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Cash flows from operating activities:
    Net loss

    $

    (24,391

    )

    $

    (11,418

    )

    $

    (44,024

    )

    $

    (44,671

    )

    Adjustments to reconcile net loss to net cash used in operating activities:
    Stock-based compensation

     

    1,919

     

     

    2,435

     

     

    7,410

     

     

    7,343

     

    Depreciation and amortization

     

    1,224

     

     

    891

     

     

    4,366

     

     

    3,808

     

    Amortization of deferred costs

     

    —

     

     

    —

     

     

    —

     

     

    1,246

     

    Non-cash operating lease expense

     

    1,286

     

     

    1,286

     

     

    5,143

     

     

    5,143

     

    Other non-cash items

     

    10

     

     

    —

     

     

    454

     

     

    —

     

    Impairment and other

     

    22,524

     

     

    1,862

     

     

    22,524

     

     

    1,862

     

    Changes in operating assets and liabilities:

     

    —

     

     

    —

     

    Accounts receivable, net

     

    (1,828

    )

     

    (990

    )

     

    (18,609

    )

     

    (4,315

    )

    Inventories

     

    (2,056

    )

     

    (3,910

    )

     

    (161

    )

     

    (5,844

    )

    Deferred costs

     

    —

     

     

    —

     

     

    —

     

     

    (467

    )

    Prepaid expenses and other current assets

     

    1,387

     

     

    1,187

     

     

    (3,846

    )

     

    533

     

    Other assets

     

    2

     

     

    (11

    )

     

    28

     

     

    (17

    )

    Accounts payable

     

    (1,465

    )

     

    2,597

     

     

    (998

    )

     

    5,884

     

    Accrued and other current liabilities

     

    (632

    )

     

    636

     

     

    (1,170

    )

     

    (747

    )

    Deferred revenue

     

    (605

    )

     

    (179

    )

     

    (1,538

    )

     

    (1,796

    )

    Deferred grant

     

    —

     

     

    —

     

     

    2,738

     

     

    —

     

    Operating lease liabilities

     

    (872

    )

     

    (471

    )

     

    (3,451

    )

     

    (1,314

    )

    Net cash used in operating activities

     

    (3,497

    )

     

    (6,085

    )

     

    (31,134

    )

     

    (33,352

    )

    Cash flows from investing activities:
    Refund from (purchase of) property, plant and equipment

     

    (2,357

    )

     

    3,627

     

     

    (4,400

    )

     

    (3,207

    )

    Net cash provided by (used in) investing activities

     

    (2,357

    )

     

    3,627

     

     

    (4,400

    )

     

    (3,207

    )

    Cash flows from financing activities:
    Proceeds from issuance of common stock in connection with the At Market Issuance Sales Agreement, net

     

    19,615

     

     

    22,555

     

     

    63,668

     

     

    33,416

     

    Proceeds from issuance of common stock upon exercise of stock warrants

     

    2,301

     

     

    —

     

     

    2,301

     

     

    14,384

     

    Payment of equity financing costs

     

    —

     

     

    —

     

     

    —

     

     

    (756

    )

    Proceeds from exercise of stock options

     

    1,172

     

     

    13

     

     

    5,071

     

     

    109

     

    Net cash provided by financing activities

     

    23,088

     

     

    22,568

     

     

    71,040

     

     

    47,153

     

    Net increase (decrease) in cash, cash equivalents and restricted cash equivalents

     

    17,234

     

     

    20,110

     

     

    35,506

     

     

    10,594

     

    Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents

     

    7

     

     

    —

     

     

    4

     

     

    —

     

    Cash, cash equivalents and restricted cash equivalents, beginning of period

     

    74,680

     

     

    36,301

     

     

    56,411

     

     

    45,817

     

    Cash, cash equivalents and restricted cash equivalents, end of period

    $

    91,921

     

    $

    56,411

     

    $

    91,921

     

    $

    56,411

     

    Reconciliation of cash, cash equivalents and restricted cash equivalents shown on the condensed consolidated balance sheets:
    Cash and cash equivalents

    $

    90,465

     

    $

    55,155

     

    $

    90,465

     

    $

    55,155

     

    Restricted cash equivalents included in prepaid expenses and other current assets

     

    200

     

     

    —

     

     

    200

     

     

    —

     

    Restricted cash equivalents included in other assets

     

    1,256

     

     

    1,256

     

     

    1,256

     

     

    1,256

     

    Total cash, cash equivalents and restricted cash equivalents

    $

    91,921

     

    $

    56,411

     

    $

    91,921

     

    $

    56,411

     

     
    AMPRIUS TECHNOLOGIES, INC.
    RECONCILIATION OF GAAP NET LOSS TO NON-GAAP ADJUSTED EBITDA
    (Unaudited, in thousands)
     
    Three months ended Year ended Outlook
    December 31,

    2025
    December 31,

    2024
    December 31,

    2025
    December 31,

    2024
    FY 2026
    GAAP Net loss

    $

    (24,391

    )

    $

    (11,418

    )

    $

    (44,024

    )

    $

    (44,671

    )

    $

    (8,000

    )

    Adjustments:
    Depreciation and amortization

     

    1,224

     

     

    891

     

     

    4,366

     

     

    3,808

     

     

    4,700

     

    Stock-based compensation

     

    1,919

     

     

    2,435

     

     

    7,410

     

     

    7,343

     

     

    8,300

     

    Impairment and other

     

    22,524

     

     

    1,862

     

     

    22,524

     

     

    1,862

     

     

    —

     

    Brighton Colorado operating costs

     

    1,568

     

     

    1,813

     

     

    6,601

     

     

    9,803

     

     

    —

     

    Interest income

     

    (1,078

    )

     

    (340

    )

     

    (2,218

    )

     

    (1,591

    )

     

    (1,000

    )

    Non-GAAP adjusted EBITDA

    $

    1,766

     

    $

    (4,757

    )

    $

    (5,341

    )

    $

    (23,446

    )

    $

    4,000

     

    We define Non-GAAP adjusted EBITDA as net loss before interest, taxes, depreciation, amortization, stock-based compensation expense and other items, which occur from time to time and which we do not believe are indicative of our core operating results.

    AMPRIUS TECHNOLOGIES, INC.
    RECONCILIATION OF GAAP NET LOSS TO NON-GAAP ADJUSTED NET LOSS
    (Unaudited, in thousands)
     
    Three months ended Year ended
    December 31,

    2025
    December 31,

    2024
    December 31,

    2025
    December 31,

    2024
    GAAP Net loss

    $

    (24,391

    )

    $

    (11,418

    )

    $

    (44,024

    )

    $

    (44,671

    )

    Impairment and other

     

    22,524

     

     

    1,862

     

     

    22,524

     

     

    1,862

     

    Non-GAAP adjusted net loss

    $

    (1,867

    )

    $

    (9,556

    )

    $

    (21,500

    )

    $

    (42,809

    )

     
    GAAP net loss per share of common stock, basic and diluted

    $

    (0.18

    )

    $

    (0.10

    )

    $

    (0.35

    )

    $

    (0.45

    )

    Adjustment per share for impairment and other

     

    0.17

     

     

    0.02

     

     

    0.18

     

     

    0.02

     

    Non-GAAP adjusted net loss per share of common stock, basic and diluted

    $

    (0.01

    )

    $

    (0.09

    )

    $

    (0.17

    )

    $

    (0.43

    )

    We define Non-GAAP adjusted net loss as net loss excluding non-recurring charges for the impairment of a right-of-use asset for the lease of the Brighton, Colorado facility and related construction-in-progress for drawings and plans at that facility as well as the retirement of certain manufacturing equipment.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260304886243/en/

    Investors

    Tom Colton, Greg Bradbury

    Gateway Group, Inc.

    949-574-3860

    [email protected]

    Media

    Zach Kadletz, Brenlyn Motlagh

    Gateway Group, Inc.

    949-574-3860

    [email protected]

    Get the next $AMPX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMPX

    DatePrice TargetRatingAnalyst
    2/23/2026$17.00Buy
    Craig Hallum
    1/29/2026$20.00Buy
    Needham
    7/18/2025Mkt Perform → Outperform
    William Blair
    1/21/2025$10.00Overweight
    Cantor Fitzgerald
    1/11/2024$10.00Buy
    ROTH MKM
    12/18/2023Mkt Perform
    William Blair
    12/5/2023$10.00Buy
    Alliance Global Partners
    10/31/2023$10.00Buy
    H.C. Wainwright
    More analyst ratings

    $AMPX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Amprius Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Business Highlights

    Q4 revenue up 137% to $25.2 million; full-year 2025 revenue up over 3X to $73.0 million Net loss of $44.0 million reflects one time impairment charges of $22.5 million as Q4 gross margin improved to 24% driving first positive quarterly non-GAAP adjusted EBITDA of $1.8 million Expecting 2026 revenue growth of at least 70% to $125 million or more, with net loss below $8 million, and positive non-GAAP Adjusted EBITDA of at least $4 million Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE:AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced financial results for the fourth quarter and full year ended December 31, 2025

    3/4/26 4:05:00 PM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    Amprius Sets March 2026 Events Schedule

    Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE:AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced its schedule for March appearances and activities. Cantor Global Technology Conference Date: March 10-11, 2026 Location: New York Hilton Midtown; New York, NY Event Details: Amprius' CEO, Tom Stepien, and CFO, Ricardo Rodriguez, will meet with investors one-on-one at the event. The management team will also participate in the Battery Storage Technology Panel on Wednesday, March 11th, at 10:40 a.m. ET. If you are interested in attending the panel or scheduling a time to meet with management, please contact your Cantor repre

    3/3/26 8:30:00 AM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    Amprius Technologies Announces Date for Fourth Quarter and Full Year 2025 Results and Business Updates

    Amprius Technologies, Inc. ("Amprius"), (NYSE:AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, will hold a conference call and webcast on Thursday, March 5, 2026 at 8:30 a.m. Eastern time (5:30 a.m. Pacific time) to discuss its financial results for the fourth quarter and full year ended December 31, 2025. Financial results will be issued in a press release prior to the call. Amprius management will host the presentation, followed by a question-and-answer period. Date: Thursday, March 5, 2026 Time: 8:30 a.m. ET (5:30 a.m. PT) Toll-Free Number: 866-424-3442 International Number: 201-689-8548 Webcast: Register and Join Please call the conference

    2/19/26 8:30:00 AM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    $AMPX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Sun Kang sold $622,035 worth of shares (61,251 units at $10.16), decreasing direct ownership by 4% to 1,342,400 units (SEC Form 4)

    4 - Amprius Technologies, Inc. (0001899287) (Issuer)

    2/24/26 5:11:23 PM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    Chief Technology Officer Stefan Constantin Ionel sold $257,604 worth of shares (25,366 units at $10.16), decreasing direct ownership by 3% to 723,330 units (SEC Form 4)

    4 - Amprius Technologies, Inc. (0001899287) (Issuer)

    2/24/26 5:08:56 PM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    Chief Technology Officer Stefan Constantin Ionel exercised 39,690 shares at a strike of $0.05 and sold $476,351 worth of shares (39,690 units at $12.00) (SEC Form 4)

    4 - Amprius Technologies, Inc. (0001899287) (Issuer)

    1/30/26 6:02:40 PM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    $AMPX
    SEC Filings

    View All

    Amprius Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Amprius Technologies, Inc. (0001899287) (Filer)

    3/4/26 4:20:12 PM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 144 filed by Amprius Technologies Inc.

    144 - Amprius Technologies, Inc. (0001899287) (Subject)

    2/24/26 5:08:05 PM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 144 filed by Amprius Technologies Inc.

    144 - Amprius Technologies, Inc. (0001899287) (Subject)

    2/24/26 5:07:16 PM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    $AMPX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Craig Hallum initiated coverage on Amprius Technologies with a new price target

    Craig Hallum initiated coverage of Amprius Technologies with a rating of Buy and set a new price target of $17.00

    2/23/26 8:35:30 AM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    Needham initiated coverage on Amprius Technologies with a new price target

    Needham initiated coverage of Amprius Technologies with a rating of Buy and set a new price target of $20.00

    1/29/26 7:00:59 AM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    Amprius Technologies upgraded by William Blair

    William Blair upgraded Amprius Technologies from Mkt Perform to Outperform

    7/18/25 7:54:43 AM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    $AMPX
    Leadership Updates

    Live Leadership Updates

    View All

    Amprius Technologies Announces CEO Transition

    Amprius President Tom Stepien appointed Chief Executive Officer by Board of Directors, effective January 1, 2026 Dr. Kang Sun to retire at the end of 2025 and will continue serving on the Amprius Board while acting as an Executive Advisor, providing strategic guidance to the Company Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE:AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced that its Board of Directors (the "Board") has appointed President Tom Stepien as its next Chief Executive Officer ("CEO"), effective January 1, 2026. This press release features multimedia. View the full release here: https://www.businesswire

    12/22/25 8:30:00 AM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    Amprius Technologies Appoints Ricardo C. Rodriguez as Chief Financial Officer

    Seasoned financial leader with extensive public company experience and a proven track record in electrification and scaling advanced technologies joins Amprius to drive next phase of growth Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE:AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced the appointment of Ricardo C. Rodriguez as Chief Financial Officer (CFO), effective immediately. As part of a planned transition and as previously disclosed, prior Company CFO Sandra Wallach is retiring and will support the Company in the short term. Rodriguez brings more than two decades of leadership experience in finance, strategy,

    10/6/25 8:30:00 AM ET
    $AMPX
    $APTV
    $ASPN
    Industrial Machinery/Components
    Miscellaneous
    Auto Parts:O.E.M.
    Consumer Discretionary

    Amprius Names Industry Veteran Tom Stepien as President to Lead Commercial Growth and Market Expansion

    Veteran Energy Executive to Deepen Customer Relationships and Accelerate Strategic Market Growth Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE:AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced the appointment of Tom Stepien as President, effective May 1, 2025. In this role, Stepien will oversee the Company's day-to-day operations, commercial growth, and market expansion to meet the accelerating demand for Amprius' high-performance silicon battery technology. Stepien has also been appointed as a member to the Company's Board of Directors, effective May 1, 2025. This press release features multimedia. View the full relea

    4/23/25 8:30:00 AM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    $AMPX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Amprius Technologies Inc.

    SC 13D - Amprius Technologies, Inc. (0001899287) (Subject)

    10/28/24 5:12:25 PM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G filed by Amprius Technologies Inc.

    SC 13G - Amprius Technologies, Inc. (0001899287) (Subject)

    10/28/24 5:03:58 PM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13D/A filed by Amprius Technologies Inc.

    SC 13D/A - Amprius Technologies, Inc. (0001899287) (Subject)

    10/25/24 7:25:57 PM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    $AMPX
    Financials

    Live finance-specific insights

    View All

    Amprius Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Business Highlights

    Q4 revenue up 137% to $25.2 million; full-year 2025 revenue up over 3X to $73.0 million Net loss of $44.0 million reflects one time impairment charges of $22.5 million as Q4 gross margin improved to 24% driving first positive quarterly non-GAAP adjusted EBITDA of $1.8 million Expecting 2026 revenue growth of at least 70% to $125 million or more, with net loss below $8 million, and positive non-GAAP Adjusted EBITDA of at least $4 million Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE:AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced financial results for the fourth quarter and full year ended December 31, 2025

    3/4/26 4:05:00 PM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    Amprius Technologies Announces Date for Fourth Quarter and Full Year 2025 Results and Business Updates

    Amprius Technologies, Inc. ("Amprius"), (NYSE:AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, will hold a conference call and webcast on Thursday, March 5, 2026 at 8:30 a.m. Eastern time (5:30 a.m. Pacific time) to discuss its financial results for the fourth quarter and full year ended December 31, 2025. Financial results will be issued in a press release prior to the call. Amprius management will host the presentation, followed by a question-and-answer period. Date: Thursday, March 5, 2026 Time: 8:30 a.m. ET (5:30 a.m. PT) Toll-Free Number: 866-424-3442 International Number: 201-689-8548 Webcast: Register and Join Please call the conference

    2/19/26 8:30:00 AM ET
    $AMPX
    Industrial Machinery/Components
    Miscellaneous

    KULR Technology Group Reports Third Quarter 2025 Financial Results

    HOUSTON, Nov. 18, 2025 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE:KULR) (the "Company" or "KULR"), a Bitcoin+ Treasury company that builds a portfolio of frontier technology businesses ranging from high-performance energy systems to AI Robotics, today reported results for the third quarter ended September 30, 2025. "KULR continues to accelerate growth and push forward our innovations," said KULR CEO Michael Mo. "With solid Q3 revenue gains and our unlevered Bitcoin holdings, we now have a more resilient balance sheet that allows us to confidently invest in next-generation KULR ONE battery products, deepen our R&D initiatives, and advance the next phase of our expansion." Third

    11/18/25 4:15:00 PM ET
    $AMPX
    $KULR
    $SLNH
    Industrial Machinery/Components
    Miscellaneous
    Electrical Products
    Technology